We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+27.4%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$409M
AUM Growth
+$1.31M
Cap. Flow
-$55.4M
Cap. Flow %
-13.56%
Top 10 Hldgs %
9.96%
Holding
345
New
97
Increased
17
Reduced
117
Closed
103

Sector Composition

Rank Sector Weight
1 Healthcare 29.79%
2 Technology 25.64%
3 Industrials 15.05%
4 Consumer Discretionary 9.18%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRGA
326
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-6,744
Closed -$1.22M
HRC
327
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-15,124
Closed -$1.6M
SWI
328
DELISTED
SolarWinds Corporation Common Stock
SWI
-54,831
Closed -$1.13M
GLUU
329
DELISTED
Glu Mobile Inc.
GLUU
-239,760
Closed -$2.62M
SMTX
330
DELISTED
SMTC Corporation
SMTX
-191,008
Closed -$722K
OXFD
331
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
-59,873
Closed -$1.03M
ACIA
332
DELISTED
Acacia Communications Inc
ACIA
-29,350
Closed -$1.68M
BSTC
333
DELISTED
BioSpecifics Technologies Corp.
BSTC
-17,696
Closed -$1.1M
WMGI
334
DELISTED
Wright Medical Group Inc
WMGI
-58,456
Closed -$1.84M
FSCT
335
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
-36,959
Closed -$1.55M
WAAS
336
DELISTED
AquaVenture Holdings Limited
WAAS
-54,608
Closed -$1.06M
DERM
337
DELISTED
Dermira, Inc.
DERM
-181,513
Closed -$2.46M
GHDX
338
DELISTED
Genomic Health, Inc.
GHDX
-14,738
Closed -$1.03M
PCMI
339
DELISTED
PCM, Inc
PCMI
-63,918
Closed -$2.34M
ARRY
340
DELISTED
Array Biopharma Inc
ARRY
-94,275
Closed -$2.3M
MEET
341
DELISTED
The Meet Group, Inc. Common Stock
MEET
-164,195
Closed -$826K
TEUM
342
DELISTED
Pareteum Corporation
TEUM
-836,097
Closed -$3.8M
ZGNX
343
DELISTED
Zogenix, Inc.
ZGNX
-12,132
Closed -$667K
BEAT
344
DELISTED
BioTelemetry, Inc.
BEAT
-35,083
Closed -$2.2M
RIBT
345
DELISTED
RiceBran Technologies
RIBT
-24,412
Closed -$908K

Similar funds

EAM Investors's Q2 2019 Portfolio in Review

As of Q2 2019, EAM Investors held 345 positions worth $409M, up 0.32% from $408M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $55.4M in Q2 2019, closing 103 positions and reducing 117 holdings. Its most notable exit was Pareteum Corporation, an estimated $3.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Upbound Group worth $2.85M.

  • EAM Investors's largest Q2 2019 buy was Upbound Group: 106,882 shares worth $2.85M.
  • EAM Investors added most to Krystal Biotech in Q2 2019, an estimated $1.92M increase.
  • EAM Investors's biggest Q2 2019 reduction was Codexis, cutting an estimated $2.65M.
  • EAM Investors fully exited Pareteum Corporation in Q2 2019, selling an estimated $3.8M.
  • EAM Investors's ten largest holdings make up 10% of its $409M portfolio in Q2 2019.
  • EAM Investors opened 97 new positions and closed 103 in Q2 2019.
  • EAM Investors's portfolio value rose 0.32% quarter-over-quarter to $409M.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.